Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The construct validity of real-world digital mobility outcomes in people with COPD

Lookup NU author(s): Dr Dimitris Megaritis, Dr Silvia Del DinORCiD, Professor Lynn RochesterORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).


Abstract

© The authors 2026. Background: Recent advances in wearable technologies make it possible to accurately quantify real-world mobility performance through technically validated digital mobility outcomes (DMOs). The aim of the present study was to evaluate the construct validity (convergent, divergent, and known-groups validity) of 24 DMOs quantifying walking activity (amount and pattern) and gait ( pace, rhythm and bout-to-bout variability) in people with COPD. Methods: Part of the Mobilise-D observational cohort study, people with COPD, recruited from seven European sites, wore an activity monitor for 7 days during daily life. Functional capacity, health status, dyspnoea, lung function, quadriceps torque and experience of difficulty with physical activity were used as constructs for convergent validity testing (Pearson/Spearman correlation coefficients). Diastolic blood pressure was used as an unrelated construct for divergent validity (criterion: |r|<0.2). Known-groups validity was evaluated across Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages (I–IV), GOLD ABE and modified Medical Research Council dyspnoea grades (linear models with p-for-trend). Results 549 participants (37% females), had mean±SD age of 68±8 years, post-bronchodilator forced expiratory volume in 1 s (FEV1) 54±20% predicted and 6-min walk distance 416±119 m. Convergent validity was supported for the majority of DMOs (17 out of 24) with correlation coefficients meeting or exceeding the a priori hypotheses by clinical experts. All DMOs supported divergent validity. 22 out of 24 DMOs distinguished between disease severity groups successfully. Expert consensus supported construct validity of 17 DMOs. Conclusions: Construct validity was supported for all walking activity (amount and pattern) DMOs, and most of the gait ( pace, rhythm, and bout-to-bout variability) DMOs, indicating the clinical utility of these measures.


Publication metadata

Author(s): Megaritis D, Long M, De Las Heras M, Alcaraz-Serrano V, Alvarez P, Becker C, Braun J, Buekers J, Buttery S, Caulfield B, Cereatti A, Chynkiamis N, Del Din S, Delgado-Ortiz L, Demeyer H, Frei A, Gimeno-Santos E, Hopkinson NS, Ionescu A, Jansen C-P, Josa-Cullere A, Kirsten A, Koch S, Lemos J, Philip KEJ, Rochester L, Sharrack B, Singleton D, Vereijken B, Vogiatzis I, Watz H, Lanfranchi V, Troosters T, Garcia-Aymerich J

Publication type: Article

Publication status: Published

Journal: ERJ Open Research

Year: 2026

Volume: 12

Issue: 2

Online publication date: 29/04/2026

Acceptance date: 05/11/2025

Date deposited: 19/05/2026

ISSN (electronic): 2312-0541

Publisher: European Respiratory Society

URL: https://doi.org/10.1183/23120541.00993-2025

DOI: 10.1183/23120541.00993-2025


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Union's Horizon 2020 research and innovation programme
Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) grant agreement number 820820

Share